Today: 8 June 2026
Gold above $4,700 revives Ray Dalio’s “new monetary order” warning as dollar jitters grow
20 January 2026
2 mins read

Gold above $4,700 revives Ray Dalio’s “new monetary order” warning as dollar jitters grow

NEW YORK, Jan 20, 2026, 09:07 EST

  • Gold and silver surged to new highs amid market jitters over tariff threats linked to Greenland
  • Ray Dalio’s 2025 prediction of a “breakdown of the monetary order” is making waves again in market talk
  • Analysts point to trade policy and interest rate uncertainty as the main factors fueling the rush into safe-haven assets

Gold jumped above $4,700 an ounce Tuesday, driven by a flight to safety following fresh U.S. tariff threats. The rally also brought Ray Dalio’s cautionary note back into focus—he warned the global financial system is edging toward a “new monetary order.”

The timing is crucial since the tariff dispute isn’t theoretical—it’s hitting prices right now. This pressure is rattling confidence in U.S. policy at a moment when investors are trying to figure out the Federal Reserve’s next move.

Dalio’s remarks hit harder since they question the U.S. dollar’s role as the world’s reserve currency — the main currency central banks stockpile and the one still dominating global trade settlements. The term “de-dollarization,” shorthand for moves to cut dependence on the greenback, usually gains traction amid simultaneous trade tensions and geopolitical strains.

Spot gold climbed 1.2% to $4,726.86 an ounce by 1131 GMT, after briefly touching $4,737.10. Silver also hit a fresh record before pulling back, Reuters reported. UBS analyst Giovanni Staunovo said the market seems to be “targeting a price of $5,000/oz.” Reuters added that traders are keeping an eye on a Supreme Court case tied to Trump’s attempt to dismiss Fed Governor Lisa Cook, a move that could raise concerns about central bank independence. Reuters

Gold and silver hit record highs on Monday as the dollar weakened and investors sought other safe havens like the Japanese yen and Swiss franc, Reuters reported. Linh Tran, senior market analyst at XS.com, called it “gold once again emerging as the preferred choice.” Citi Research set near-term targets at $5,000 for gold and $100 for silver. Meanwhile, money markets are betting on at least two 25-basis-point Fed cuts this year (a basis point equals one-hundredth of a percentage point). Reuters

Ray Dalio, founder of Bridgewater Associates, sounded the alarm in an April 2025 NBC interview about a “breaking down of the monetary order,” Livemint reports. He described tariffs as “rocks thrown into the production system” and slammed Trump’s tactics as “very disruptive” for sparking “global conflict.” Dalio also warned the next downturn might be worse than a typical recession. mint

That message isn’t a dated forecast. Think of it as a stress-test scenario: what if politics keeps disrupting bonds, currencies, and trade flows?

The warning has been making rounds again on markets and crypto-focused platforms, injecting fresh noise into an already volatile tape.

Some analysts expect the tariff threats to soften during negotiations. Wedbush’s Dan Ives called it “bark will be worse than the bite,” with markets eyeing the World Economic Forum in Davos and early moves ahead of trade talks. AP News

The big question about the “reserve currency” rarely hinges on one news cycle. Despite gold’s sharp rally, the dollar remains supported by the depth of U.S. financial markets and a global payments network centered on it. A quick easing of tariffs or persistently high U.S. rates could just as quickly slow the surge into non-yielding gold.

Stock Market Today

  • Indian Stock Market July 8: Cautious Start Amid Middle East Tensions
    June 8, 2026, 9:21 AM EDT. Indian stocks are poised for a cautious open on June 8, impacted by rising Middle East tensions and a global market selloff. The GIFT Nifty index fell over 1%, as Asian markets including South Korea and Japan declined sharply, signaling increased investor risk aversion. Higher crude oil prices and a rebound in gold indicate a shift towards defensive assets. Investors will watch key domestic developments in companies like TVS Motor, RailTel, KNR Constructions, Creative Newtech, Amber Enterprises, and Ixigo. Fundraising activities at Zee, ASM Technologies, and Gujarat Themis, along with regulatory issues at Yes Bank, 5Paisa, and Reliance Infrastructure, will also remain in focus.

Latest articles

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
ABAT Shares Jump on DOE’s $115M Lithium Grant Return

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

8 June 2026
American Battery Technology Co shares soared 29.58% to $4.03 premarket after the U.S. Department of Energy fully reinstated a $115 million grant for its Nevada lithium refinery, restoring federal funding for the Tonopah Flats Lithium Project with no change to awarded funds or milestones, though risks remain from permitting, financing, and volatile lithium prices.
NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
UPL share price slips as Advanta IPO papers hit SEBI: what the filing reveals
Previous Story

UPL share price slips as Advanta IPO papers hit SEBI: what the filing reveals

Intel stock slides premarket despite HSBC upgrade as tariff jitters hit tech
Next Story

Intel stock slides premarket despite HSBC upgrade as tariff jitters hit tech

Go toTop